HemAware

Featured On HemAware

Why Has Gene Therapy for Hemophilia Been Slow to Catch On?

After years of excitement about a possible “one-and-done” treatment, gene therapy uptake has been slower than expected. Here’s why.
Read More
What Are Biosimilars? A Guide for People with Bleeding Disorders

Similar to biologic medications, this type of therapy is safe and effective and could expand your access to treatment.
Read More
OhmBody: A New Approach to Therapy for Heavy Menstrual Bleeding

The wearable wellness device works without medications or hormones and complements other bleeding disorder treatments.
Read More

OhmBody: A New Approach to Therapy for Heavy Menstrual Bleeding

In a rapidly changing hemophilia treatment landscape, shared decision-making helps patients and providers choose the option that fits best.

Taking Charge, Hemophilia A&B

It took years for Julie Schiffmacher to be diagnosed with von Willebrand disease. Now she’s turning that experience into advocacy.

My Journey

These two bleeding disorders share some similarities but are also unique in significant ways. Here’s what you need to know.

Hemophilia A&B, Von Willebrand Disease

Shared decision-making (SDM) is a process in which a patient and their health care team work together to make decisions...

Global Focus

Having a bleeding disorder shouldn’t keep you from seeing the world. Just ask Devin Smith, a recent college graduate in...

Generation Next

With abortion access restricted in many states and sexually transmitted infections (STIs) on the rise nationwide, having a conversation with...

Family Matters

Each year, hundreds of women, girls, and people with the potential to menstruate (WGPPM) who are affected by bleeding disorders...

Chapter Roundup

Need Information about Bleeding Disorders?

Contact The Neil Frick Resource Center (NFRC)